200 related articles for article (PubMed ID: 29043425)
1. Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype.
Salazar-González RA; Turiján-Espinoza E; Hein DW; Niño-Moreno PC; Romano-Moreno S; Milán-Segovia RC; Portales-Pérez DP
Arch Toxicol; 2018 Feb; 92(2):661-668. PubMed ID: 29043425
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid.
Butcher NJ; Ilett KF; Minchin RF
Biochem Pharmacol; 2000 Dec; 60(12):1829-36. PubMed ID: 11108798
[TBL] [Abstract][Full Text] [Related]
3. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
Jefferson FA; Xiao GH; Hein DW
Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
[TBL] [Abstract][Full Text] [Related]
4. Phenotype of the most common "slow acetylator" arylamine N-acetyltransferase 1 genetic variant (NAT1*14B) is substrate-dependent.
Millner LM; Doll MA; Cai J; States JC; Hein DW
Drug Metab Dispos; 2012 Jan; 40(1):198-204. PubMed ID: 22010219
[TBL] [Abstract][Full Text] [Related]
5. Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells.
Butcher NJ; Ilett KF; Minchin RF
Mol Pharmacol; 2000 Mar; 57(3):468-73. PubMed ID: 10692486
[TBL] [Abstract][Full Text] [Related]
6. Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.
Cribb AE; Isbrucker R; Levatte T; Tsui B; Gillespie CT; Renton KW
Pharmacogenetics; 1994 Jun; 4(3):166-70. PubMed ID: 7920698
[TBL] [Abstract][Full Text] [Related]
7. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes.
Leggett CS; Doll MA; States JC; Hein DW
Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180
[TBL] [Abstract][Full Text] [Related]
8. Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells.
Wise JTF; Salazar-González RA; Habil MR; Doll MA; Hein DW
Toxicol Appl Pharmacol; 2022 May; 442():115993. PubMed ID: 35353990
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of arylamine N-acetyltransferase 1 (NAT1) NAT1*10 haplotypes in a complete NATb mRNA construct.
Millner LM; Doll MA; Stepp MW; States JC; Hein DW
Carcinogenesis; 2012 Feb; 33(2):348-55. PubMed ID: 22114069
[TBL] [Abstract][Full Text] [Related]
10. NATb/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenyl.
Millner LM; Doll MA; Cai J; States JC; Hein DW
Mol Carcinog; 2012 Aug; 51(8):636-46. PubMed ID: 21837760
[TBL] [Abstract][Full Text] [Related]
11. Expression and genotype-dependent catalytic activity of N-acetyltransferase 2 (NAT2) in human peripheral blood mononuclear cells and its modulation by Sirtuin 1.
Salazar-González RA; Turiján-Espinoza E; Hein DW; Milán-Segovia RC; Uresti-Rivera EE; Portales-Pérez DP
Biochem Pharmacol; 2018 Oct; 156():340-347. PubMed ID: 30149019
[TBL] [Abstract][Full Text] [Related]
12. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1).
Bruhn C; Brockmöller J; Cascorbi I; Roots I; Borchert HH
Biochem Pharmacol; 1999 Dec; 58(11):1759-64. PubMed ID: 10571250
[TBL] [Abstract][Full Text] [Related]
13. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations.
Butcher NJ; Ilett KF; Minchin RF
Pharmacogenetics; 1998 Feb; 8(1):67-72. PubMed ID: 9511183
[TBL] [Abstract][Full Text] [Related]
14. Functional effects of single nucleotide polymorphisms in the coding region of human N-acetyltransferase 1.
Zhu Y; Hein DW
Pharmacogenomics J; 2008 Oct; 8(5):339-48. PubMed ID: 17909564
[TBL] [Abstract][Full Text] [Related]
15. Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predisposition.
Fretland AJ; Doll MA; Zhu Y; Smith L; Leff MA; Hein DW
Cancer Detect Prev; 2002; 26(1):10-4. PubMed ID: 12088197
[TBL] [Abstract][Full Text] [Related]
16. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
18. Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes.
Cribb AE; Grant DM; Miller MA; Spielberg SP
J Pharmacol Exp Ther; 1991 Dec; 259(3):1241-6. PubMed ID: 1762071
[TBL] [Abstract][Full Text] [Related]
19. Assessment of arylamine N-acetyltransferase (NAT1) activity in mononuclear leukocytes of cystic fibrosis patients.
Cribb AE; Tsui B; Isbrucker R; Michael RT; Gillespie CT; Brown-Bonomo J; Barrett P; Levatte T; Renton KW
Br J Clin Pharmacol; 1995 Jan; 39(1):85-9. PubMed ID: 7756106
[TBL] [Abstract][Full Text] [Related]
20. N-Acetylation of p-aminobenzoic acid and p-phenylenediamine in primary porcine urinary bladder epithelial cells and in the human urothelial cell line 5637.
Föllmann W; Blaszkewicz M; Behm C; Degen GH; Golka K
J Toxicol Environ Health A; 2012; 75(19-20):1206-15. PubMed ID: 22994574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
